Literature DB >> 11327800

Gene transfer into cultured mammalian embryos by electroporation.

N Osumi1, T Inoue.   

Abstract

To gain a better understanding of mammalian development at the molecular level, technology is needed that allows the transfer of exogenous genes into desired embryonic regions at defined stages of development. Our strategy has been to use electroporation (EP) of plasmid DNA following whole-embryo culture (WEC). In our gene transfer system, postimplantation rodent embryos are taken out of the uterus and a purified DNA solution of mammalian expression plasmid constructs is injected into the neural tube. A square-pulse current is delivered using an electroporator with an optimizer. Electroporated embryos are allowed to develop in the WEC system for 24--48 h. Within the targeted area, the proportion of transfected cells varied from 10% to approximately 100% depending on the test conditions (e.g., DNA concentration, voltage, duration of EP, and pulse number). The EP--WEC system has several advantages including rapid gene expression, minimal laboratory work, precisely targeted regions, and no risk for human beings. Application of the method is useful in improving our understanding of early neural development (E7--E12 in mice), e.g., alteration of gene function via ectopic expression, interference with dominant negative proteins, and fate mapping with marker genes. In addition, EP can complement genetic approaches such as the generation of knockout and transgenic mice. Copyright 2001 Academic Press.

Entities:  

Mesh:

Year:  2001        PMID: 11327800     DOI: 10.1006/meth.2001.1154

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  33 in total

1.  Optimized conditions for transgenesis of the ascidian Ciona using square wave electroporation.

Authors:  David A Vierra; Steven Q Irvine
Journal:  Dev Genes Evol       Date:  2012-01-13       Impact factor: 0.900

2.  A new approach to manipulate the fate of single neural stem cells in tissue.

Authors:  Elena Taverna; Christiane Haffner; Rainer Pepperkok; Wieland B Huttner
Journal:  Nat Neurosci       Date:  2011-12-18       Impact factor: 24.884

3.  Cyclin D2 in the basal process of neural progenitors is linked to non-equivalent cell fates.

Authors:  Yuji Tsunekawa; Joanne M Britto; Masanori Takahashi; Franck Polleux; Seong-Seng Tan; Noriko Osumi
Journal:  EMBO J       Date:  2012-03-06       Impact factor: 11.598

4.  CyclinD2 at the edge: splitting up cell fate.

Authors:  Federico Calegari
Journal:  EMBO J       Date:  2012-03-27       Impact factor: 11.598

5.  The method of rodent whole embryo culture using the rotator-type bottle culture system.

Authors:  Masanori Takahashi; Noriko Osumi
Journal:  J Vis Exp       Date:  2010-08-28       Impact factor: 1.355

Review 6.  Multiple strategies for gene transfer, expression, knockdown, and chromatin influence in mammalian cell lines and transgenic animals.

Authors:  Félix Recillas-Targa
Journal:  Mol Biotechnol       Date:  2006-11       Impact factor: 2.695

7.  Electroporation: an arsenal of application.

Authors:  Ti-Fei Yuan
Journal:  Cytotechnology       Date:  2007-06-16       Impact factor: 2.058

8.  DSCAM is a netrin receptor that collaborates with DCC in mediating turning responses to netrin-1.

Authors:  Alice Ly; Anatoly Nikolaev; Geetha Suresh; Yufang Zheng; Marc Tessier-Lavigne; Elke Stein
Journal:  Cell       Date:  2008-06-27       Impact factor: 41.582

9.  Patterned assembly and neurogenesis in the chick dorsal root ganglion.

Authors:  Lynn George; Jennifer Kasemeier-Kulesa; Branden R Nelson; Naoko Koyano-Nakagawa; Frances Lefcort
Journal:  J Comp Neurol       Date:  2010-02-15       Impact factor: 3.215

10.  Microfluidic generation of transient cell volume exchange for convectively driven intracellular delivery of large macromolecules.

Authors:  Anna Liu; Muhymin Islam; Nicholas Stone; Vikram Varadarajan; Jenny Jeong; Sam Bowie; Peng Qiu; Edmund K Waller; Alexander Alexeev; Todd Sulchek
Journal:  Mater Today (Kidlington)       Date:  2018-04-17       Impact factor: 31.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.